BRKR241220C52500
- 7.30
- 0.000.00%
Bruker Corp Newsroom
Bruker Coverage Assumed by UBS at Neutral Vs Previous Rating of Buy
UBS Downgrades Bruker Corp(BRKR.US) to Hold Rating, Cuts Target Price to $66
UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102
Goldman Sachs Upgrades Bruker Corp(BRKR.US) to Hold Rating
This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Bruker Price Target Maintained With a $60.00/Share by Goldman Sachs
Bruker Raised to Neutral From Sell by Goldman Sachs
Express News | Goldman Sachs Upgrades Bruker to Neutral, Maintains Price Target to $60
Bruker Analyst Ratings
Bruker Stock Might Rise From the Launch of Dimension Nexus AFM
Bruker Introduces Dimension Nexus Atomic Force Microscope
Due to differences in valuation, brookfield asset management (BAM.US) has abandoned the privatization of grifols (GRFS.US).
Following reports from multiple media outlets that Canadian asset management company Brookfield Asset Management has abandoned the plan to privatize Grifols, the plasma therapy company's stock price plummeted in pre-market trading on Wednesday.
Trending Industry Today: American Superconductor Leads Gains In Room-Temp Superconductors Stocks
Bruker Shares Are Trading Higher After the Company's President and CEO Disclosed Share Purchases.
Express News | Bruker Shares Are Trading Higher After the Company's President and CEO Disclosed Share Purchases
Citi Research's 'SMID Value' Rec List – CHWY, FHN, PODD, and More
Bruker Jumps as CEO Buys $5M Company Stock
Bruker Up Nearly 10%, On Pace for Largest Percent Increase Since November 2019 -- Data Talk
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday
Bruker Insider Bought Shares Worth $5,014,069, According to a Recent SEC Filing